Speech-Language Pathologists in Mobile, AL Accepting Medicare

126 Speech-Language Pathologists found. Showing 121 - 126

Maureen Hynes Willoughby Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4401 Winding Way, Mobile, AL 36693 Phone: 251-661-5102    Fax: 251-661-6595

Mrs. Lynda Diane Maniscalco, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9221 Champion Cir. South, Mobile, AL 36695 Phone: 251-599-5953

Mrs. Deborah Cooksey Walker, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3715 Dauphin Street, Suite 6-c, Mobile, AL 36608 Phone: 251-340-7950    Fax: 251-344-0870

Mrs. Ashton Callaghan Robinson, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6312 Piccadilly Square Dr, Suite 3, Mobile, AL 36609 Phone: 251-287-0378    Fax: 251-287-0466

Dr. Kimberly Ann Graham Smith, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5721 Usa Dr N, Hahn 119, Mobile, AL 36688 Phone: 251-445-9365    Fax: 251-445-9376

Laura Adlington Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 273 Azalea Rd, Mobile, AL 36609 Phone: 251-380-0492

News Archive

Study shows that 14-3-3 sigma opposes, reverses tumor-promoting metabolic programs

Every parent knows the maxim "feed a cold, starve a fever." In cancer, however, exactly how to feed or starve a tumor has not been easy to determine.

Scientists discover 12 genetic markers for ED in prostate cancer patients after radiotherapy

In the first study of its kind, a research team led by Mount Sinai School of Medicine and Albert Einstein College of Medicine of Yeshiva University discovered 12 genetic markers associated with the development of erectile dysfunction (ED) in prostate cancer patients who were treated with radiation.

BioBehavioral Diagnostics completes $10M Series B financing round

BioBehavioral Diagnostics (BioBDx), a privately held company which manufactures and markets the Quotient™ ADHD System, a tool that aids in the objective and accurate assessment of attention-deficit hyperactivity disorder (ADHD), announced today the first close of a $10 million Series B financing.

Internet-based diet and exercise program shows promise in lowering healthcare costs

Researchers from Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH) have shown that an employer-sponsored, internet-based diet and exercise program shows promise as a low-cost benefit to lower healthcare costs for those at higher risk for above-average costs and healthcare utilization such as cardiac, hyperlipidemia, hypertension or diabetes patients.

AAN neurologist receives prestigious award at Palatucci Advocacy Leadership Forum

The American Academy of Neurology(AAN) has named neurologist Constantine Moschonas, MD, of Scottsdale, Ariz., as the AAN Donald M. Palatucci Advocacy Leadership Forum Advocate of the Year. Moschonas received his award at the Palatucci Advocacy Leadership Forum on January 14, 2012, in Austin, Texas, for his outstanding work in raising awareness about brain diseases such as Alzheimer's disease, stroke, autism, Parkinson's disease and multiple sclerosis.

Read more Medical News

› Verified 9 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7(current)